Alx Oncology Holdings Inc (ALXO) Company Profile & Statistics

Alx Oncology Holdings Inc
ALXO
(Nasdaq - US)
N/A
15.76
+0.40 (+2.60%)
in:usd•As of: May 06, 2024 15:59 UTC -4
Open
15.69
High
16.45
Low
15.55

About Alx Oncology Holdings Inc

CEO

Jason Lettmann

Headquarters

323 allerton avenue

south san francisco, ca 94080, united states

Auditor

KPMG LLP

Employees

Share Holders

Website

www.alxoncology.com

Industry

biotechnology

Sector

health technology

Company Overview

ALX Oncology Holdings Inc.is a clinical-stage immuno-oncology company. It focuses on developing therapies for patients fighting cancer. The company's product candidate consist ALX148, which is in clinical stage. ALX Oncology Holdings Inc.is based in Burlingame, California.

Alx Oncology Holdings Inc Statistics

Valuation Measures

Market Capitalization ²	788M
Enterprise Value	775.23M
Enterprise Value/EBITDA (ttm)	-4.41
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	4.03
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-76.10%
Return on Invested Capital (ttm)	-78.86%
Return on Assets (ttm)	-62.59%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-175.68M
Net Income Avi to Common (ttm)	-160.81M
Diluted EPS (ttm)	-3.75

Share Statistics

Beta (5Y Monthly)	1.30
52-Week Change	157.10%
S&P500 52-Week Change	27.73%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	50.15M
Dividend Yield	0.00%
Float ⁴	24.85M
% Held by Insiders	50.30%
% Held by Institutions	97.97%

Balance Sheet

Total Cash (mrq)	182.74M
Total Cash Per Share (mrq)	3.64
Total Debt (mrq)	9.64M
Total Debt/Equity (mrq)	5.08%
Current Ratio (mrq)	5.24%
Quick Ratio (mrq)	5.24%
Book Value Per Share (mrq)	3.80

Cash Flow

Operating Cash Flow Per Share (ytd)	-3.03
Free Cash Flow (ytd)	-131.64M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Alx Oncology Holdings Inc

Trade With A Regulated Broker